Benztropine Mesylate description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Benztropine Mesylate

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BENZTROPINE MESYLATE DESCRIPTION




Benztropine Mesylate




CLINICAL PHARMACOLOGY





INDICATIONS & USAGE


PRECAUTIONS

BENZTROPINE MESYLATE CONTRAINDICATIONS




WARNINGS






PRECAUTIONS

General







WARNINGS

CONTRAINDICATIONS

BENZTROPINE MESYLATE ADVERSE REACTIONS












OVERDOSAGE


Manifestations


Treatment



DOSAGE & ADMINISTRATION





Postencephalitic and Idiopathic Parkinsonism








Drug-Induced Extrapyramidal Disorders




HOW SUPPLIED










PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Benztropine Mesylate

Benztropine Mesylate

Benztropine Mesylate

Benztropine Mesylate TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:24236-015(NDC:50111-393)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
BENZTROPINE MESYLATE BENZTROPINE 0.5 mg

Inactive Ingredients

Ingredient Name Strength
ANHYDROUS LACTOSE
cellulose, microcrystalline
SILICON DIOXIDE
SODIUM STARCH GLYCOLATE TYPE A POTATO
MAGNESIUM STEARATE

Product Characteristics

Color Size Imprint Code Shape
white 6 mm b;1114 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:24236-015-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA089058 2011-09-06


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.